CILIBERTO, DOMENICO
 Distribuzione geografica
Continente #
AS - Asia 153
EU - Europa 133
NA - Nord America 120
SA - Sud America 42
AF - Africa 4
Totale 452
Nazione #
US - Stati Uniti d'America 113
SG - Singapore 74
IT - Italia 65
BR - Brasile 38
DE - Germania 35
CN - Cina 20
VN - Vietnam 16
FI - Finlandia 13
IN - India 12
HK - Hong Kong 11
NL - Olanda 6
CA - Canada 5
ID - Indonesia 5
GB - Regno Unito 4
TR - Turchia 4
IQ - Iraq 3
JP - Giappone 3
RU - Federazione Russa 3
AR - Argentina 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
ZA - Sudafrica 2
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
ES - Italia 1
FR - Francia 1
GE - Georgia 1
KE - Kenya 1
LB - Libano 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
SE - Svezia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 452
Città #
Singapore 34
Munich 30
Dallas 20
Carbonia 12
Turku 12
Ashburn 11
Bengaluru 11
Hefei 11
Hong Kong 11
Ho Chi Minh City 9
Chicago 8
Santa Clara 8
The Dalles 6
Chandler 5
New York 5
Rome 5
São Paulo 5
Beijing 4
Ercolano 4
London 4
Los Angeles 4
Hanoi 3
Manaus 3
Naples 3
Nuremberg 3
Porto Alegre 3
Tokyo 3
Afragola 2
Boardman 2
Montreal 2
Olomouc 2
Reggio Calabria 2
San Nicola Manfredi 2
West Lafayette 2
Alvorada 1
Amsterdam 1
Ancol 1
Ankara 1
Atlanta 1
Augusta 1
Balıkesir 1
Baqubah 1
Bay City 1
Beirut 1
Benevento 1
Biên Hòa 1
Bragança Paulista 1
Brasília 1
Buffalo 1
Cabreúva 1
Caicó 1
Campina Grande 1
Cape Town 1
Chaguanas 1
Charlotte 1
Chennai 1
Cleveland 1
Cosenza 1
Crestview 1
Curitiba 1
Dolores Hidalgo 1
Florianópolis 1
Ginosa 1
Helsinki 1
Isidro Casanova 1
Istanbul 1
Itabira 1
Itambaracá 1
Itapemirim 1
Itariri 1
Jacarezinho 1
Jaraguá do Sul 1
Johannesburg 1
La Paz 1
Lahore 1
Lajeado 1
Landshut 1
Limeira 1
Louisville 1
Menzel Temime 1
Milan 1
Moscow 1
Mosul 1
Nairobi 1
Nasiriyah 1
Niterói 1
Norwich 1
Nova Iguaçu 1
Osasco 1
Padang 1
Palermo 1
Penápolis 1
Pesqueira 1
Petrópolis 1
Pittsburgh 1
Ponto Belo 1
San Hilario 1
Satuba 1
Seattle 1
Siziano 1
Totale 317
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 96
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 62
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 57
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 40
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 36
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis 32
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 31
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 31
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 30
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis 26
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 24
Totale 465
Categoria #
all - tutte 3.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20238 0 0 0 1 0 2 0 2 0 2 1 0
2023/202451 15 2 6 1 1 6 1 0 0 1 12 6
2024/2025215 10 3 0 6 7 32 9 7 14 4 61 62
2025/2026191 26 39 38 33 43 12 0 0 0 0 0 0
Totale 465